DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

about

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

Item

http://www.wikidata.org/entity/Q36384979

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

@ast

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

@en

type

Item

label

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

@ast

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

@en

prefLabel

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

@ast

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells.

@en

P1476

DEK protein level is a biomarker of CD138positive normal and malignant plasma cells

@en

P2093

Ahmet Özdilek

http://www.w3.org/2001/XMLSchema#string

Amma Bosompem

http://www.w3.org/2001/XMLSchema#string

Annette S Kim

http://www.w3.org/2001/XMLSchema#string

Bülent Saka

http://www.w3.org/2001/XMLSchema#string

Emrah Özçelik

http://www.w3.org/2001/XMLSchema#string

Gerard Grosveld

http://www.w3.org/2001/XMLSchema#string

Türkan Çakar

http://www.w3.org/2001/XMLSchema#string

Zihni Onur Çalışkaner

http://www.w3.org/2001/XMLSchema#string

Öner Doğan

http://www.w3.org/2001/XMLSchema#string

P2860

Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer.

Reintroduction of CEBPA in MN1-overexpressing hematopoietic cells prevents their hyperproliferation and restores myeloid differentiation

Subcellular localization of the human proto-oncogene protein DEK

ONCOMINE: a cancer microarray database and integrated data-mining platform

C/EBP and DEK coordinately regulate myeloid differentiation

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Relationships linking amplification level to gene over-expression in gliomas

A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival.

Control of tumorigenesis and chemoresistance by the DEK oncogene

The human DEK proto-oncogene is a senescence inhibitor and an upregulated target of high-risk human papillomavirus E7

P304

e0178025

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0178025

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Ayten Kandilci

P577

2017-05-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28558048

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

P932

5448761

http://www.w3.org/2001/XMLSchema#string